GSDME and pulmonary hypertension: Through its caspase-3-dependent activation and pore-forming capacity, GSDME converts apoptotic signals into secondary pyroptosis, amplifying tissue inflammation and injury in conditions such as atherosclerosis, myocardial infarction, cardiomyopathy, and pulmonary hypertension.